Cargando…
Organizing Pneumonia Induced by Tocilizumab in a Patient with Rheumatoid Arthritis
Interstitial lung disease is a significant extra-articular manifestation of rheumatoid arthritis, due to its prevalence, morbidity and mortality. Biological therapies are widely used for rheumatoid arthritis treatment. However, some biological agents have been related to the induction or exacerbatio...
Autores principales: | Gouveia, Pedro A, Ferreira, Eduarda Carneiro Gomes, Cavalcante Neto, Paulo M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075508/ https://www.ncbi.nlm.nih.gov/pubmed/32201660 http://dx.doi.org/10.7759/cureus.6982 |
Ejemplares similares
-
An Analysis of Rheumatoid Arthritis Hospitalizations
por: Kannayiram, Sandhya Shri, et al.
Publicado: (2020) -
Rheumatoid Vasculitis: Is It Always a Late Manifestation of Rheumatoid Arthritis?
por: Anwar, Muhammad M, et al.
Publicado: (2019) -
A Case of Rheumatoid Arthritis-Associated Interstitial Lung Disease - An Unfortunate Complication of Untreated Rheumatoid Arthritis!
por: Ruggiero, Raffaele A, et al.
Publicado: (2020) -
Vitamin D Deficiency in Saudi Patients With Rheumatoid Arthritis
por: Alharbi, Samar, et al.
Publicado: (2023) -
Rare Overlap of Granulomatosis With Polyangiitis in a Patient With Rheumatoid Arthritis
por: Grzybacz, David, et al.
Publicado: (2021)